使用多标准优化进行功能性肺回避计划
本研究为前瞻性临床试验,纳入38例III期非小细胞肺癌患者,在放疗前进行68Ga-4D-V/Q正电子发射断层扫描/计算机断层扫描,利用知识库计划创建解剖基线计划,再用多标准优化生成功能适应性计划。结果显示所有患者的高功能肺体积均成功得到保护,36例患者的功能肺体积得到保护,解剖学定义危及器官剂量无临床显著差异,但计划靶区近最大和最小剂量存在差异;功能平均肺剂量有统计学显著降低,而功能肺接受20 Gy体积无显著降低。
要点
- 使用多标准优化进行功能性肺回避计划可行,所有38例患者高功能肺体积均成功得到保护。
- 36例患者功能肺体积成功得到保护,解剖学定义危及器官剂量无临床显著差异。
- 功能平均肺剂量有统计学显著降低,功能肺接受20 Gy体积无显著降低。
核心结论
- 使用多标准优化进行功能性肺回避计划可行,但确实导致计划靶区覆盖范围发生变化。
- 使用多标准优化的一个明显优势是所有关于功能性肺回避的代价和获益决策均可实时做出。
研究设计与样本
- 前瞻性临床试验U1111-1138-4421,纳入72例患者,其中38例III期非小细胞肺癌患者符合进入本计划研究的条件。
- 患者在放疗前接受68Ga-4D-V/Q正电子发射断层扫描/计算机断层扫描,使用通气与灌注肺定义高功能肺和功能肺靶体积。
- 使用知识库计划创建解剖基线计划,再使用多标准优化生成功能适应性计划,由临床医生使用多标准优化工具选择最终功能性肺回避计划。
主要发现
- 高功能肺体积在所有患者中均成功得到保护,功能肺体积在38例患者中的36例成功得到保护。
- 解剖学定义危及器官的剂量无临床显著差异,计划靶区近最大和最小剂量存在差异。
- 整个研究人群中,功能平均肺剂量有统计学显著降低,但功能肺接受20 Gy体积无统计学显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Functional lung avoidance (FLA) radiation therapy is an evolving field. The aim of FLA planning is to reduce dose to areas of functioning lung, with comparable target coverage and dose to organs at risk. Multicriteria optimization (MCO) is a planning tool that may assist with FLA planning. This study assessed the feasibility of using MCO to adapt radiation therapy plans to avoid functional regions of lung that were identified using a 68Ga-4D-V/Q positron emission tomography/computed tomography. METHODS AND MATERIALS: A prospective clinical trial U1111-1138-4421 was performed in which patients had a 68Ga-4D-V/Q positron emission tomography/computed tomography before radiation treatment. Of the 72 patients enrolled in this trial, 38 patients had stage III non-small cell lung cancer and were eligible for selection into this planning study. Functional lung target volumes HF lung (highly functioning lung) and F lung (functional lung) were defined using the ventilated and perfused lung. Using knowledge-based planning, a baseline anatomic plan was created, and then a functional adapted plan was generated using multicriteria optimization. The primary aim was to spare dose to HF lung. Using the MCO tools, a clinician selected the final FLA plan. Dose to functional lung, target volumes, organs at risk and measures of plan quality were compared using standard statistical methods. RESULTS: The HF lung volume was successfully spared in all patients. The F lung volume was successfully spared in 36 of the 38 patients. There were no clinically significant differences in dose to anatomically defined organs at risk. There were differences in the planning target volume near maximum and minimum doses. Across the entire population, there was a statistically significant reduction in the functional mean lung dose but not in the functional volume receiving 20 Gy. All trade-off decisions were made by the clinician. CONCLUSIONS: Using MCO for FLA was achievable but did result in changes to planning target volume coverage. A distinct advantage in using MCO was that all decisions regarding the cost and benefits of FLA could be made in real time.
引用
- Bucknell N, Hardcastle N, McIntosh L, et al. Functional Lung Avoidance Planning Using Multicriteria Optimization. Pract Radiat Oncol. 2024. PMID: 38705233. doi:10.1016/j.prro.2024.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。